Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company, founded on 1 July 1992. It is among the top 500 Indian companies by market capitalization ^[1]

History

1. 1992-1995- The company obtained certificate of Commencement of business in 1992. In 1993, the company became a public company. In 1995, it started commercial production and received GMP certification.
2. 1996-1999- Orchid Pharmaceuticals received ISO certification for quality systems, ISO 9002 certification and ISO certification for Environment Management Systems. It became the country's largest producer of oral and sterile cephalosporin and was ranked^{[by whom?]} among the top five producers of cephalosporin APIs. The formulation division of Orchid Pharmaceutical became operational too.
3. 2000-2003- The company received ISO 9001-2000 certification. The company grew inorganically by making multiple alliances and acquisitions and became a global company by setting its offices in USA and Russia.
4. 2004-2007- It signs agreement to produce oral cephalosporins for US market. The company's joint venture with Bexel completed its phase 1(a), phase 1(b), phase 2(a)clinical trials for anti-diabetic molecule- BLX-1002 and got the patent clearance from USA.Enters in the Canadian market, makes agreements with leading pharmaceuticals to participate in manufacturing and marketing of oral drugs and veterinary injectable, and licensing and distribution alliances for Europe market.
5. 2008-2010- Approvals to enter Canadian and Australian market, establishes a wholly owned subsidiary in Japan. The company keep on growing through innovating new molecules and also inorganically by acquisitions and different license and collaborations in the market for generic drugs, antibiotics and injectables.

Orchid trust works focuses on initiatives and growth in the areas of

• Education
• Health
• Self-employment
• Capacity building
• Community asset development

Human resources

Orchid Pharma boasts of the "Orchidian Spirit" and assumes that this spirit makes it a best place to work with. Orchid treats its employees as most valuable assets and follows an entrepreneurial approach to achieve high performance of its employees by working in a collaborative management way. It has a workforce of over 4000 employees. Human Resource department at Orchid Pharma work at its best to provide equal opportunities to all for growth and development. Orchid Pharma believes that the value system and the work culture has provided them overcome the difficult times together and they are proud of their people.

Value creation

Orchid Pharma has created value through continuous innovation, quality and consistent delivery of best products. Its end-to-end connected infrastructure is a key driver of the growth in diverse and differentiated drug discovery and development, as the infrastructure enables the complete value-chain integration. The Research & Development division is creating value by Process and Pharma Research, New Drug Discovery,Pre-Clinical Research, Novel Drug Delivery Systems,Biotech Research, IP Management, Contract Research and Manufacturing (CRAM) Services.

Products

Orchid Pharmaceuticals prepares mainly 2 type of products

1. Active Pharamaceuticals Ingredients- It includes Cephalosporins (Oral & Injectables),Non-antibiotics, Carbapenems, Penicillins.*[1]
2. Formulations (Domestic)- It includes Cardio, Anti-Diabetic, Neuropsychiatry and Critical care formulations.*[2]

Production facilities

Orchid Pharma is a vertically integrated global pharma company. It has established 3 research campuses, 3 formulations manufacturing sites and 2 API manufacturing sites in India; and 1 API manufacturing site in China. R&D facilities are accredited by National GLP Authority of India and Manufacturing facilities are approved by US Food and Drug Administration, UK Medicines and Healthcare products Regulatory Agency (MHRA), European Directorate for the Quality of Medicines (EDQM), DMA^{[disambiguation needed ]}, MCC^{[disambiguation needed ]} and the Australian Therapeutic Goods Administration (TGA).

Financials

Orchid Pharma securities are traded at NSE^{[disambiguation needed ]}, BSE^{[disambiguation needed ]}, MSE^{[disambiguation needed ]}, and Singapore Stock Exchange. As per March 2011 report,*[3] Total asset value is 3155 crores INR (approx) including fixed assets of 2206 crores INR. The Annual Revenue is 1594.68 crores INR with a net profit ~ 159.5 crores INR. Total number of public shares is 48939460, with EPS 22.64. As on June 2011, Market Capital value stands at 1991.40 crores INR.

Environmental initiatives

Orchid Pharma is one of the few "zero discharge" pharmaceuticals facilities in India. Due to its green policies, it has been appreciated by Government of India, CII^{[disambiguation needed ]} and many apex organizations^[who?] for maintaining high environmental safety practices. It possesses ISO 14001-Quality certification for its Quality Environmental Management Systems.

To maintain the high environmental safety, Orchid Pharma takes help of various technologies such as vent-gas condensation, solvent recirculation, reverse osmosis, mobile vehicle with excellent monitoring systems to continuously check the quality of ambient air in and around the manufacturing facilities. It possesses a world class effluent treatment infrastructure

Awards

Orchid Pharma has won many awards^[2] in the field of Quality, Safety, Environmental Safety, CSR. It also has received awards for Management Excellence, Partnership and Employer -Employee relationship. *[4]

References

1. ^ http://www.dnb.co.in/Top500_2008/company_listing.asp?PageNo=17&q=Market_Cap&r=
2. ^ http://www.indiacsr.in/article-1895-Orchid-Pharma-Founder-Chairman-K-Raghavendra-Rao-awarded-with-Padma-Shri-award.html

External links

• Official Website of Orchid Chemicals & Pharmaceuticals Limited